{"entity":{"type":"insider","cik":"0001734033","url":"/insider/0001734033","json_url":"/insider/0001734033.json","name":"Matthews Judith M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2018-05-30","last":"2022-03-15","span_basis":"filed_date"},"name_variants":[{"name":"Matthews Judith M.","source":"filing","n_filings":5,"first_seen":"2018-05-30","last_seen":"2022-03-15"}],"transactions":[{"id":9271693,"accession":"0001209191-22-018976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018976","line_url":"/filing/0001209191-22-018976#line-1","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734033","owner_name":"Matthews Judith M.","owner_url":"/insider/0001734033","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63340.0,"shares_display":"63,340","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":19635.4,"total_display":"19,635.40","shares_owned_after":65292.0,"shares_owned_after_display":"65,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-15","scope":"insider"},{"id":6890668,"accession":"0001209191-22-018864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-018864","line_url":"/filing/0001209191-22-018864#line-2","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734033","owner_name":"Matthews Judith M.","owner_url":"/insider/0001734033","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47132.0,"shares_display":"47,132","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":17910.16,"total_display":"17,910.16","shares_owned_after":81500.0,"shares_owned_after_display":"81,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-15","scope":"insider"},{"id":4811292,"accession":"0000899243-21-003518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-003518","line_url":"/filing/0000899243-21-003518#line-2","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734033","owner_name":"Matthews Judith M.","owner_url":"/insider/0001734033","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33868.0,"shares_display":"33,868","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":58591.64,"total_display":"58,591.64","shares_owned_after":28632.0,"shares_owned_after_display":"28,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider"},{"id":3162112,"accession":"0000899243-20-027008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-027008","line_url":"/filing/0000899243-20-027008#line-1","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734033","owner_name":"Matthews Judith M.","owner_url":"/insider/0001734033","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56130.0,"shares_display":"56,130","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":92053.2,"total_display":"92,053.20","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-30","filed_date":"2020-10-02","scope":"insider"},{"id":5964683,"accession":"0001209191-18-034193","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034193","line_url":"/filing/0001209191-18-034193#line-4","is_derivative":false,"issuer_cik":"0001659323","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001659323","owner_cik":"0001734033","owner_name":"Matthews Judith M.","owner_url":"/insider/0001734033","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":52000.0,"total_display":"52,000.00","shares_owned_after":56130.0,"shares_owned_after_display":"56,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2018-05-30","last_seen":"2022-03-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001734033","retrieved_at":"2026-08-21T18:08:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}